stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
X 4 Pharmaceuticals IncXFOR
$2.960.67%-0.02
After Hours: 2.93-0.03 -1.01%

X 4 Pharmaceuticals Inc (XFOR)

X 4 Pharmaceuticals Inc stock is traded at $2.96, with a volume of 1,116,895. It is down -0.67% in the last 24 hours and up +7.64% over the past month. X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
Previous Close:
$2.98
Open:
$2.94
24h Volume:
1,116,895
Relative Volume:
1.26
Market Cap:
$302.26M
Revenue:
$9.01M
Net Income/Loss:
-$99.72M
P/E Ratio:
-
EPS:
-$4.54
Net Cash Flow:
-$92.85M
1W Performance:
-6.62%
1M Performance:
+7.64%
6M Performance:
-18.68%
1Y Performance:
-18.90%
1-Day Range:
$2.88$3.05
1-Week Range:
$2.77$3.27
52-Week Range:
$2.43$4.83

X 4 Pharmaceuticals Inc Stock (XFOR) Company Profile

Name
X 4 Pharmaceuticals Inc
Phone
857-529-8300
Address
61 NORTH BEACON STREET, BOSTON, MA, USA
Employee
45
Next Earnings Date
-
Latest SEC Filings
SEC
XFOR's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

X 4 Pharmaceuticals Inc Stock (XFOR) Financials Data

Similar to XFOR